Doxepin Suppliers & Bulk Manufacturers
Available Forms: Cream
Available Strengths: 5%
Reference Brands: Silenor(US); Sinequan, Aponal(EU)
Category:
Antipsychotropic Drugs
Doxepin, available in capsules, tablets, oral solution, and topical cream, treats depression, anxiety, insomnia, and itching. Brands include Silenor, Zonalon (US), and Sinequan (EU). Its multi-indication use across psychiatry and dermatology makes it a strategic product for pharma B2B suppliers targeting US and EU pharmaceutical markets.
Doxepin is available in Cream
and strengths such as 5%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Doxepin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Doxepin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Doxepin is a tricyclic antidepressant used to treat depression, anxiety, insomnia, and pruritus. It is available in multiple forms including capsules (10–150 mg), oral solution (10 mg/mL), and topical cream (5%) for dermatological use. In the US, Silenor (3 mg, 6 mg) is marketed for sleep disorders, while Zonalon is used for skin conditions. In the EU, it is available under brand names like Sinequan and Aponal. Doxepin’s versatility in psychiatric and dermatologic therapy makes it a valuable addition to pharma B2B catalogs, ideal for suppliers targeting mental health, sleep, and dermatology segments in regulated markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing